ESC Professional Premium Access

Chronic outcomes of leadless vs transvenous single chamber ventricular pacemakers in high-risk subgroups

Topic: Antibradycardia Pacing

Congress Presentation

About the speaker

Mr Lucas Higuera

Medtronic, Mounds View (United States of America)
0 follower

5 more presentations in this session

Clinical impact of "minimal" right ventricular pacing on atrial arrhythmias: results from the prospective multi-center worldwide EMERALD study.

Speaker: Doctor A. Di Cori (Pisa, IT)


Mortality and 30-day readmission rate following leadless pacemaker implantation: insights from the Nationwide Readmissions Database

Speaker: Doctor R. Tonegawa-Kuji (Suita, JP)


Evaluation of the association between right ventricular lead placement and future need for upgrade from pacemaker or ICD to cardiac resynchronization therapy. A population-based comparative study

Speaker: Associate Professor R. Borgquist (Lund, SE)


Acute hemodynamic effects of biventricular pacing studied during cardiovascular magnetic resonance imaging: The PICARIA Trial

Speaker: Mr L. Hopman (Amsterdam, NL)


Intracardiac echocardiographically guided permanent pacemaker implantation is a feasible imaging tool with comparable procedural efficacy and safety

Speaker: Professor S. Shin (Seoul, KR)


Access the full session

Pacing innovations

Speakers: Mr L. Higuera, Doctor A. Di Cori, Doctor R. Tonegawa-Kuji, Associate Professor R. Borgquist, Mr L. Hopman...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk